We are exposed to a large number of man-made chemicals. This creates combinations of chemical mixtures, to which we are subjected during our whole lifespan. Current risk assessment and management practices, however, focus mainly on exposure to single substances. Exposure to hazardous substances, especially endocrine disrupting chemicals (EDCs), during the foetal period is of particular concern, as it can lead to irreversible changes in the development of organs and tissues and increased susceptibility to diseases later in life.
The EU Horizon 2020 EDC-MixRisk project (https://edcmixrisk.ki.se/), which has now reached its conclusion, was initiated to investigate how effects caused by real-life relevant mixtures could be studied. The project, composed by researchers from several Swedish, European and one U.S. university, developed a novel approach based on identifying and testing EDC mixtures associated with adverse health outcomes in humans.
By using epidemiology data from the Swedish pregnancy cohort SELMA (a cohort of more than 2300 pregnant women), reference mixtures were created to mimic real life exposures (at concentrations found in the pregnant women). These mixtures were tested in various experimental (cell and animal) models, and the toxicological data from these tests were used to establish new methods and strategies for mixture risk assessment in order to better account for complex environmental exposures. Professor Åke Bergman, coordinator of the project, says “the novel whole mixture approach applied in EDC-MixRisk has allowed us to assess the number of mothers in the SELMA cohort that are at risk for effects in their children, effects related to growth and metabolism, neurodevelopment and sexual development”.
Further, researchers in Prof. Testa’s laboratory in Milano spearheaded the use of human brain organoids to directly assess the impact of such mixtures on the closest available model of the developing human brain. They uncovered that even at real life concentrations, EDCs interfere with the same regulatory networks that are already involved in the genetic forms of autism spectrum disorder and intellectual disability. “This new method enables the investigation of relevant chemical exposures on equally relevant windows of sensitivity during human brain development.” Prof. Testa points out.
In Paris, the team of Prof. Demeneix investigated whether the mixtures interfered with brain development and growth through modulation of thyroid hormone signalling. Prof. Demeneix underlines that “Thyroid hormone is essential for brain development and children born to mothers that have insufficient thyroid hormone also have increased risk of autism spectrum disorder and IQ loss. Thyroid hormone signalling and numerous thyroid hormone dependent genes were disrupted by the mixture in the different models tested. These findings reveal a mechanism whereby brain development is affected by exposure to the chemicals at relevant human exposure levels.”
An overarching conclusion from the EDC-MixRisk project is that current regulations of man-made chemicals systematically underestimate health risks associated with combined exposures to EDCs or potential EDCs.
EDC-MixRisk is launching a Policy Brief which is including key results, overarching conclusions and future needs as well as some further project highlights as part of the workshop, The Chemical Cocktail Challenge, at Thon Hotel EU, Brussels, on Tuesday March 26th. The workshop is organized jointly with the EuroMix project, highlighting the main results and conclusions from the two H2020-funded projects, EDC-MixRisk and EuroMix, and their implications for future needs for chemical mixture risk assessment.
Prof. Åke Bergman, Coordinator of EDC-MixRisk,
email@example.com, Tel: +46 70 644 3861
Ass. Prof. Joëlle Rüegg, Vice-Coordinator of EDC-MixRisk
firstname.lastname@example.org, Tel: +46 73 712 1592
Short facts about EDC-MixRisk:
The project focuses on the effects of mixtures of endocrine-disrupting chemicals on children – with the ultimate aim of promoting safer use of chemicals.
Full name: “Integrating Epidemiology and Experimental Biology to Improve Risk Assessment of Exposure to Mixtures of Endocrine Disruptive Compounds — EDC-MixRisk”
Project period: from 2015-05-01 to 2019-05-01
Funding: EU H2020 project, EC contribution EUR 6 223 330, Grant agreement No 634880